Albemarle is a specialty chemicals business based in the US. Albemarle shares (ALB) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $72.25 – a decrease of 3.34% over the previous week. Albemarle employs 8,300 staff and has a trailing 12-month revenue of around $5.4 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $72.25 |
|---|---|
| 52-week range | $66.85 - $135.07 |
| 50-day moving average | $80.08 |
| 200-day moving average | $90.87 |
| Wall St. target price | $101.31 |
| PE ratio | N/A |
| Dividend yield | $1.61 (2.17%) |
| Earnings per share (TTM) | $-11.20 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $71.82 from 2025-04-01
| 1 week (2025-03-26) | -5.15% |
|---|---|
| 1 month (2025-03-03) | 2.67% |
| 3 months (2025-01-03) | -18.19% |
| 6 months (2024-10-03) | -23.85% |
| 1 year (2024-04-02) | -43.22% |
|---|---|
| 2 years (2023-03-31) | -66.59% |
| 3 years (2022-04-01) | 217.3762 |
| 5 years (2020-04-02) | 41.49% |
Valuing Albemarle stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Albemarle's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Albemarle's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9896. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Albemarle's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $5.4 billion |
|---|---|
| Operating margin TTM | 1.77% |
| Gross profit TTM | $84.2 million |
| Return on assets TTM | -2.14% |
| Return on equity TTM | -11.43% |
| Profit margin | -21.93% |
| Book value | $65.72 |
| Market Capitalization | $8.5 billion |
TTM: trailing 12 months
Dividend payout ratio: 57.97% of net profits
Recently Albemarle has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Albemarle shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Albemarle's case, that would currently equate to about $1.61 per share.
Albemarle's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Albemarle's most recent dividend payout was on 31 March 2025. The latest dividend was paid out to all shareholders who bought their shares by 13 March 2025 (the "ex-dividend date").
Albemarle's shares were split on a 2:1 basis on 1 March 2007 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Albemarle shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Albemarle shares which in turn could have impacted Albemarle's share price.
Over the last 12 months, Albemarle's shares have ranged in value from as little as $66.8539 up to $135.0663. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Albemarle's is 1.704. This would suggest that Albemarle's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FCX, with 24-hour and historical pricing before you buy.